Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Because many of the sales of these medications are coming from off-label weight loss prescriptions, once orforglipron is approved -- even if only initially for type 2 diabetes -- we can expect demand and sales to be robust
Common injection sites used in trials include: The abdomen (at least 5 cm away from the navel) The upper thigh The upper arm (outer aspect) Rotating injection sites with each weekly dose is recommended to reduce the risk of localised skin reactions such as bruising or injection site discomfort
When to Seek Professional Guidance for Your Weight Loss Stall If you've maintained stable weight for 8+ weeks despite consistent effort and medication adherence, contact your healthcare provider or PlexusDx care team for a medication review
Meanwhile, Ozempic goes off patent in Canada next year, and in the US by 2032, potentially opening the door to more affordable access and generic competition
This sounds very promising
NCT05296733 Investigators
